r78c
Vaccineexperimental
Clinical trial activity
3 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2022 (NCT05385471)
Timeline
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07183371 | Phase 2 | Nov 30, 2025 | European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Government of Germany, Institut et Haute école de la Santé, La Source, University of Oxford |
| NCT06958198 | Phase 1 | Sep 15, 2025 | European and Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, Government of Germany, Institut et Haute école de la Santé, La Source, University of Oxford, Wellcome Trust |
| NCT05385471 | Early Phase 1 (Phase 1) | Nov 1, 2022 | Churchill Hospital, Oxford, University of Oxford |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 3 | 3 | 2 | 2022 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 2 | 0 | 2 | 2025 |
| European Vaccine Initiative (EVI), Heidelberg, Germany | Government | 2 | 0 | 2 | 2025 |
| Government of Germany | Government | 2 | 0 | 2 | 2025 |
| Institut et Haute école de la Santé, La Source | Academic/Hospital | 2 | 0 | 2 | 2025 |
| Churchill Hospital, Oxford | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2025 |
7 organizations
Page 1 / 1